Literature DB >> 30784136

In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii.

Thaís Felli Kubiça1,2, Laura Bedin Denardi1,2, Érico Silva de Loreto1, Gilson Zeni3, Carla Weiblen1, Vanessa Oliveira1, Janio Morais Santurio1, Sydney Hartz Alves1.   

Abstract

This study evaluated the in vitro susceptibility of Trichosporon asahii strains to diphenyl diselenide (DPDS) and ebselen (EBS) alone and in combination with amphotericin B (AMB), fluconazole (FCZ), itraconazole (ITZ) and caspofungin (CAS) using the microdilution method. EBS showed in vitro activity against T asahii strains with minimal inhibitory concentration (MIC) ranged from 0.25 to 8.0 μg/mL. For DPDS, the MIC ranged from 8.0 to 64 μg/mL. The combinations demonstrating the greatest synergism rate against fluconazole-resistant T asahii strains were the following: CAS + DPDS (96.67%), AMB + DPDS (93.33%), FCZ + DPDS (86.67%) and ITZ + DPDS (83.33%). The combinations AMB + DPDS and AMB + EBS exhibited the highest synergism rate against the fluconazole-susceptible (FS) T asahii strains (90%). Antagonism was observed in the following combinations: FCZ + EBS (80%) and FCZ + DPDS (13.33%) against the FS strains, and ITZ + EBS (20%) against the FR strains. Our findings suggest that the antimicrobial activity of DPDS and EBS against T. asahii and its use as an adjuvant therapy with antifungal agents warrant in vivo experimental investigation.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  fluconazole resistance; interactions; microdilution; organoselenium compounds; susceptibility

Mesh:

Substances:

Year:  2019        PMID: 30784136     DOI: 10.1111/myc.12906

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  In Vitro Activity of Ebselen and Diphenyl Diselenide Alone and in Combination with Drugs against Trichophyton mentagrophytes Strains.

Authors:  Sebastian Gnat; Dominik Łagowski; Mariusz Dyląg; Grzegorz Jóźwiak; Aleksandra Trościańczyk; Aneta Nowakiewicz
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

Review 2.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

3.  Efficacy of Ebselen Against Invasive Aspergillosis in a Murine Model.

Authors:  Karina Mayumi Sakita; Isis Regina Grenier Capoci; Pollyanna Cristina Vincenzi Conrado; Franciele Abigail Vilugron Rodrigues-Vendramini; Daniella Renata Faria; Glaucia Sayuri Arita; Tânia Cristina Alexandrino Becker; Patricia de Souza Bonfim-Mendonça; Terezinha Inez Estivalet Svidzinski; Erika Seki Kioshima
Journal:  Front Cell Infect Microbiol       Date:  2021-06-23       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.